S&P 500
1987.98
+0.97 +0.05%
Dow Indu
17083.80
-2.83 -0.02%
Nasdaq
4473.47
-0.23 -0.01%
Crude Oil
102.02
-0.05 -0.05%
Gold
1291.310
-1.090 -0.08%
Euro
1.346755
+0.000255 +0.02%
US Dollar
80.843
-0.025 -0.03%
Weak

MILK CLASS III Jul 2014 (E) Future

Chicago Mercantile ExchangeMILK CLASS III Jul 2014 (E) (CME:DC.N14.E)

21.53 +0.01 (+0.05%)

2014-07-24 17:07:15, 10 min delay

MILK CLASS III Jul 2014 (E) (CME:DC.N14.E) Future Chart
1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Max
Last Price21.53
Settle Time17:07
Previous Close21.53
Low21.54
Open Int.4191
Contract High22.03
Contract Low16.72
Estimated Volume19
Open Time18:00
Net Change0.01
Open21.57
High21.58
Volume120
Time2014-07-24 17:07:15
Contract High Date2014-06-24
Contract Low Date2013-08-15
Expiration2014-07-29
Close Time17:00

Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.

First Name
Last Name
Email
 
By filling out the form, you'll receive instant access to Today's Top 50 Trending Stocks list and other trading resources from INO.com.

List of Top Stocks


Trader's Blog

Three Reasons Why Gold and Gold Stocks Will Rise
   11 hours ago
Have Natural Gas Prices Hit Bottom?
   15 hours ago
I Know Where You Can Find Winning Stocks To Trade
   1 day ago

Today's Financial News

House votes to simplify tax breaks for higher education, excluding some graduate students

7 hours ago

WASHINGTON (AP) — The House has passed a bill to simplify a complicated patchwork of tax breaks for higher education. But some higher education officials oppose the bill because many graduate students and older students would lose their tax breaks. That's because students could only claim the credit in the first four years of college.

FDA accepts first application for approval of a biosimilar drug, could decide in 10 months

7 hours ago

WASHINGTON, D.C. (AP) — The Food and Drug Administration is reviewing research data on what could become the first U.S.-approved "biosimilar" drug, a cheaper, sort-of generic version of a biologic drug. The FDA is evaluating Swiss drugmaker Novartis AG's application to sell a biosimilar version of Neupogen, which brought maker Amgen Inc. $1.4 billion in sales last year. Neupogen, known chemically as filgrastim, treats a dangerous decrease in infection-fighting white blood cells, common in cancer patients getting certain treatments.

Michigan officials tell Enbridge to install more support anchors beneath Great Lakes oil pipes

7 hours ago

TRAVERSE CITY, Mich. (AP) — Two oil pipelines at the bottom the waterway linking Lakes Huron and Michigan will get additional support structures to help prevent potentially devastating spills, officials said Thursday. As a condition of an easement granted by the state, Enbridge agreed that support anchors would be placed at least every 75 feet. In a response last month to a lengthy series of questions about the condition of the lines from Schuette and Wyant, the Canadian company acknowledged some sections don't meet the requirement, although the average distance between supports is 54 feet.

FAA lifts ban on US flights to Tel Aviv after reassessing danger from Hamas rockets

7 hours ago

WASHINGTON (AP) — The Federal Aviation Administration has lifted its ban on U.S. flights in and out of Israel. The end of the ban, which the agency had imposed out of concern for the risk of planes being hit by Hamas rockets, was effective at 11:45 p.m. EDT Wednesday. "Before making this decision, the FAA worked with its U.S. government counterparts to assess the security situation in Israel and carefully reviewed both significant new information and measures the government of Israel is taking to mitigate potential risks to civil aviation," the FAA said. "The agency will continue to closely monitor the very fluid situation around Ben Gurion Airport and will take additional actions as necessary."

INO.com on Facebook INO.com MarketClub on Twitter INO.com on Google+ INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.